BISCODYL

BISCODYL was reported 13186 times

BISCODYL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HYPOKINETIC DYSARTHRIA 23 0.7667
1 VAGINAL FLATULENCE 187 0.6172
2 APPENDICOLITH 206 0.5323
3 ANTACID THERAPY 67 0.5154
4 SLEEP DISORDER THERAPY 101 0.5101
5 TOTAL LUNG CAPACITY INCREASED 102 0.3750
6 ANALGESIC THERAPY 98 0.3053
7 DRUG THERAPY 94 0.2773
8 CONGENITAL HIATUS HERNIA 61 0.2675
9 MALIGNANT MELANOMA STAGE 0 50 0.2392
10 ANTICOAGULANT THERAPY 64 0.2254
11 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 102 0.1950
12 IVTH NERVE PARALYSIS 42 0.1772
13 VICTIM OF CHILD ABUSE 42 0.1673
14 BACTEROIDES INFECTION 41 0.1571
15 CEREBRAL HYPOPERFUSION 73 0.1567
16 EPIDURAL LIPOMATOSIS 52 0.1512
17 CHILD ABUSE 38 0.1467
18 CAPILLARITIS 37 0.1341
19 BINOCULAR EYE MOVEMENT DISORDER 35 0.1215
20 SEDATION COMPLICATION 304 0.1190
21 FEMALE GENITAL TRACT FISTULA 198 0.1159
22 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 107 0.1154
23 TOTAL LUNG CAPACITY ABNORMAL 42 0.1080
24 MULTIPLE DRUG THERAPY 79 0.1048
25 CEREBELLAR STROKE 35 0.0895
26 PULMONARY VASCULITIS 46 0.0855
27 RADICULOPATHY 199 0.0754
28 SPIROMETRY ABNORMAL 44 0.0736
29 MITE ALLERGY 47 0.0718
30 COLONIC PSEUDO-OBSTRUCTION 20 0.0714
31 CREATININE RENAL CLEARANCE DECREASED 284 0.0709
32 CREATININE RENAL CLEARANCE INCREASED 52 0.0695
33 PROCTITIS 193 0.0688
34 CHRONIC SINUSITIS 256 0.0681
35 MACULAR DEGENERATION 787 0.0658
36 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 47 0.0641
37 HYPERPHOSPHATAEMIA 135 0.0627
38 LEUKOPLAKIA 15 0.0612
39 BLOOD PHOSPHORUS INCREASED 156 0.0571
40 MYCOTIC ALLERGY 47 0.0550
41 TOTAL LUNG CAPACITY DECREASED 85 0.0532
42 HYPOMANIA 185 0.0503
43 JAUNDICE CHOLESTATIC 176 0.0498
44 DUST ALLERGY 47 0.0479
45 PNEUMOCOCCAL INFECTION 24 0.0405
46 PLEURITIC PAIN 95 0.0344
47 CONJUNCTIVITIS ALLERGIC 49 0.0331
48 INTESTINAL PSEUDO-OBSTRUCTION 29 0.0330
49 OROMANDIBULAR DYSTONIA 24 0.0329
50 LUNG OPACITY 85 0.0322
51 NEURITIS 49 0.0317
52 RESPIRATORY SYMPTOM 84 0.0295
53 DYSPRAXIA 16 0.0284
54 BLOOD CALCIUM DECREASED 302 0.0268
55 IGA NEPHROPATHY 44 0.0265
56 BRONCHIECTASIS 178 0.0264
57 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 27 0.0254
58 PLICATED TONGUE 12 0.0252
59 RHINITIS ALLERGIC 111 0.0249
60 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 49 0.0240
61 APPENDICITIS 217 0.0232
62 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 117 0.0231
63 ORTHOSTATIC HYPOTENSION 399 0.0229
64 IRON DEFICIENCY 102 0.0227
65 JUVENILE IDIOPATHIC ARTHRITIS 54 0.0221
66 BLOOD URIC ACID INCREASED 126 0.0218
67 NASAL POLYPS 107 0.0217
68 SARCOIDOSIS 103 0.0217
69 SCHIZOPHRENIA 251 0.0206
70 HYPOPHOSPHATAEMIA 152 0.0205
71 HYPORESPONSIVE TO STIMULI 23 0.0196
72 AORTIC STENOSIS 66 0.0189
73 MYASTHENIA GRAVIS 153 0.0189
74 VENTRICULAR FIBRILLATION 210 0.0189
75 VAGINAL DISCHARGE 189 0.0187
76 NEPHROGENIC ANAEMIA 86 0.0185
77 NORMOCHROMIC NORMOCYTIC ANAEMIA 55 0.0183
78 REDUCED FACIAL EXPRESSION 17 0.0167
79 PARAESTHESIA ORAL 238 0.0165
80 HYPERPARATHYROIDISM SECONDARY 41 0.0163
81 ORAL CANDIDIASIS 215 0.0163
82 RENAL FUNCTION TEST ABNORMAL 74 0.0159
83 CARDIOGENIC SHOCK 225 0.0157
84 FORCED EXPIRATORY VOLUME DECREASED 44 0.0155
85 HYPOGONADISM 15 0.0148
86 SLOW RESPONSE TO STIMULI 18 0.0139
87 SEDATION 355 0.0135
88 BLOOD CALCIUM INCREASED 117 0.0133
89 EFFUSION 18 0.0132
90 CARDIAC MURMUR 113 0.0130
91 RALES 75 0.0129
92 ASPIRATION 134 0.0122
93 END STAGE RENAL DISEASE 223 0.0122
94 TROPONIN INCREASED 90 0.0118
95 BENIGN PROSTATIC HYPERPLASIA 60 0.0116
96 BREATH SOUNDS ABNORMAL 54 0.0109
97 REBOUND ACID HYPERSECRETION 33 0.0109
98 RESPIRATORY DEPRESSION 133 0.0108
99 OBSTRUCTIVE AIRWAYS DISORDER 116 0.0104
100 ON AND OFF PHENOMENON 55 0.0099
101 ARTERIOSCLEROSIS CORONARY ARTERY 64 0.0097
102 COGNITIVE DISORDER 451 0.0096
103 MUTISM 14 0.0096
104 PULMONARY ALVEOLAR HAEMORRHAGE 54 0.0096
105 TONGUE DRY 13 0.0096
106 MULTIPLE ORGAN DYSFUNCTION SYNDROME 264 0.0093
107 ORAL MUCOSAL EXFOLIATION 14 0.0092
108 ASCITES 271 0.0092
109 NEUROLOGICAL SYMPTOM 52 0.0091
110 NEURALGIA 219 0.0090
111 CHOLELITHIASIS 289 0.0088
112 EXCESSIVE EYE BLINKING 13 0.0088
113 FULL BLOOD COUNT ABNORMAL 92 0.0087
114 MICTURITION URGENCY 98 0.0086
115 HYPERLIPIDAEMIA 102 0.0085
116 DEPRESSED LEVEL OF CONSCIOUSNESS 336 0.0085
117 BLOOD TEST ABNORMAL 117 0.0083
118 PRODUCT MONITORING ERROR 12 0.0083
119 HEPATOTOXICITY 185 0.0083
120 SEBORRHOEIC KERATOSIS 12 0.0083
121 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 141 0.0082
122 BACTERIAL INFECTION 153 0.0082
123 CLOSTRIDIUM TEST POSITIVE 18 0.0082
124 ANTICHOLINERGIC SYNDROME 13 0.0082
125 PROCEDURAL PAIN 224 0.0081
126 NEUROGENIC BLADDER 17 0.0080
127 LUNG NEOPLASM 34 0.0080
128 FREQUENT BOWEL MOVEMENTS 215 0.0080
129 BLOOD BILIRUBIN INCREASED 213 0.0079
130 ARTERIOSCLEROSIS 74 0.0079
131 SPUTUM DISCOLOURED 70 0.0074
132 HYPONATRAEMIA 399 0.0071
133 GLOSSITIS 25 0.0070
134 STOMA SITE ERYTHEMA 13 0.0070
135 PULMONARY FIBROSIS 132 0.0069
136 PSYCHOTIC DISORDER 203 0.0069
137 CONSTIPATION 1495 0.0068
138 ULCER 108 0.0068
139 DECUBITUS ULCER 55 0.0067
140 HYPOXIA 237 0.0067
141 SUBILEUS 14 0.0067
142 LARGE INTESTINAL ULCER 18 0.0066
143 MONOCYTE COUNT INCREASED 24 0.0066
144 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 11 0.0066
145 ATELECTASIS 62 0.0064
146 COLITIS 241 0.0064
147 FAILURE TO THRIVE 33 0.0063
148 PULMONARY MASS 93 0.0062
149 JUGULAR VEIN THROMBOSIS 11 0.0062
150 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 313 0.0060
151 METABOLIC ENCEPHALOPATHY 18 0.0060
152 GOUT 107 0.0060
153 RECTAL HAEMORRHAGE 255 0.0059
154 LISTLESS 19 0.0058
155 HEPARIN-INDUCED THROMBOCYTOPENIA 28 0.0057
156 UROSEPSIS 52 0.0056
157 BALANCE DISORDER 481 0.0056
158 HOSTILITY 14 0.0055
159 HYPERCHOLESTEROLAEMIA 53 0.0055
160 CANCER PAIN 14 0.0055
161 MOBILITY DECREASED 381 0.0053
162 WOUND COMPLICATION 18 0.0052
163 TRANSAMINASES INCREASED 116 0.0052
164 LYMPHOCYTOSIS 11 0.0051
165 FAECALOMA 28 0.0051
166 NON-CARDIAC CHEST PAIN 16 0.0051
167 HAEMOPTYSIS 141 0.0050
168 PARESIS 11 0.0049
169 BLADDER DISORDER 49 0.0049
170 FUNCTIONAL GASTROINTESTINAL DISORDER 17 0.0049
171 COLITIS ISCHAEMIC 33 0.0049
172 LIVER FUNCTION TEST INCREASED 105 0.0049
173 SMALL INTESTINAL OBSTRUCTION 60 0.0049
174 RED CELL DISTRIBUTION WIDTH INCREASED 20 0.0048
175 TONGUE DISCOLOURATION 21 0.0048
176 STOMA SITE DISCHARGE 13 0.0047
177 ILEUS PARALYTIC 21 0.0047
178 ESCHERICHIA BACTERAEMIA 11 0.0047
179 GASTROINTESTINAL MOTILITY DISORDER 25 0.0047
180 AORTIC ARTERIOSCLEROSIS 12 0.0047
181 VASCULITIS 54 0.0046
182 COLITIS ULCERATIVE 207 0.0046
183 HAEMATOCHEZIA 253 0.0046
184 BLOOD ALBUMIN DECREASED 36 0.0045
185 PRODUCT PRESCRIBING ERROR 108 0.0045
186 NOCTURIA 55 0.0045
187 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 321 0.0045
188 CHRONIC KIDNEY DISEASE 340 0.0045
189 OBESITY 71 0.0045
190 FRUSTRATION TOLERANCE DECREASED 36 0.0045
191 TENDERNESS 46 0.0044
192 CLUMSINESS 12 0.0044
193 CATHETER SITE HAEMORRHAGE 11 0.0044
194 SEPSIS 487 0.0044
195 OSTEITIS 11 0.0044
196 IMMOBILE 19 0.0043
197 FREEZING PHENOMENON 16 0.0043
198 LUNG CONSOLIDATION 12 0.0043
199 ENDOTRACHEAL INTUBATION 12 0.0043
200 DYSCHEZIA 13 0.0043
201 NEUTROPHIL COUNT INCREASED 43 0.0042
202 GENERAL PHYSICAL HEALTH DETERIORATION 483 0.0042
203 PNEUMONIA ASPIRATION 104 0.0042
204 WHEEZING 246 0.0041
205 INFUSION RELATED REACTION 274 0.0041
206 LUMBAR SPINAL STENOSIS 12 0.0041
207 ACUTE RESPIRATORY FAILURE 79 0.0041
208 LOCALISED OEDEMA 19 0.0041
209 GAMBLING DISORDER 11 0.0041
210 AZOTAEMIA 16 0.0040
211 PLEURAL EFFUSION 243 0.0040
212 NODULE 51 0.0039
213 TUBULOINTERSTITIAL NEPHRITIS 73 0.0039
214 ECONOMIC PROBLEM 59 0.0039
215 HYPERURICAEMIA 16 0.0039
216 MENTAL STATUS CHANGES 108 0.0039
217 BONE LESION 14 0.0039
218 ABDOMINAL DISTENSION 403 0.0039
219 RESPIRATORY RATE DECREASED 12 0.0038
220 FOREIGN BODY 15 0.0037
221 NECROTISING FASCIITIS 13 0.0037
222 ANAEMIA 703 0.0037
223 MUSCLE SPASTICITY 45 0.0037
224 BLOOD CREATININE INCREASED 238 0.0036
225 SPINAL OSTEOARTHRITIS 32 0.0036
226 CRANIOCEREBRAL INJURY 11 0.0036
227 HYPERNATRAEMIA 18 0.0036
228 PROSTATE CANCER METASTATIC 12 0.0036
229 PETIT MAL EPILEPSY 18 0.0035
230 HYPOTENSION 705 0.0035
231 RENAL FAILURE CHRONIC 27 0.0035
232 JOINT INJURY 75 0.0035
233 URINARY RETENTION 117 0.0035
234 FEELING COLD 97 0.0035
235 LEUKOCYTOSIS 63 0.0035
236 CORONARY ARTERY DISEASE 105 0.0035
237 RENAL TUBULAR NECROSIS 34 0.0035
238 HYPOKALAEMIA 159 0.0034
239 HOSPICE CARE 34 0.0034
240 HYPOVOLAEMIA 20 0.0034
241 UNRESPONSIVE TO STIMULI 88 0.0034
242 GASTROOESOPHAGEAL REFLUX DISEASE 271 0.0034
243 PULSELESS ELECTRICAL ACTIVITY 14 0.0033
244 DYSARTHRIA 126 0.0033
245 BLOOD CHOLESTEROL INCREASED 156 0.0033
246 HYPOVOLAEMIC SHOCK 16 0.0033
247 SPINAL CORD COMPRESSION 13 0.0033
248 ABDOMINAL PAIN 767 0.0033
249 ANXIETY DISORDER 11 0.0033
250 PROCTALGIA 21 0.0033
251 OEDEMA PERIPHERAL 392 0.0032
252 PELVIC FRACTURE 25 0.0032
253 UPPER RESPIRATORY TRACT INFECTION 148 0.0032
254 LOWER RESPIRATORY TRACT INFECTION 145 0.0032
255 PROTEIN TOTAL DECREASED 12 0.0032
256 ODYNOPHAGIA 19 0.0032
257 DEMENTIA 88 0.0031
258 PULMONARY EMBOLISM 298 0.0031
259 MALNUTRITION 35 0.0031
260 GINGIVAL DISORDER 12 0.0031
261 ANAL INCONTINENCE 28 0.0031
262 DELIRIUM 108 0.0031
263 THERAPEUTIC PRODUCT EFFECT DELAYED 14 0.0031
264 ESCHERICHIA URINARY TRACT INFECTION 13 0.0031
265 ENCEPHALOPATHY 75 0.0031
266 ABSCESS LIMB 13 0.0030
267 RESPIRATION ABNORMAL 21 0.0030
268 IRON DEFICIENCY ANAEMIA 28 0.0030
269 SLEEP DISORDER 214 0.0030
270 CEREBRAL ATROPHY 12 0.0030
271 ACUTE KIDNEY INJURY 459 0.0030
272 DYSPEPSIA 295 0.0030
273 FLUID INTAKE REDUCED 15 0.0030
274 STAPHYLOCOCCAL BACTERAEMIA 13 0.0030
275 GRANULOCYTOPENIA 17 0.0030
276 DIVERTICULUM INTESTINAL 13 0.0030
277 PRESYNCOPE 72 0.0030
278 HAEMORRHAGIC ANAEMIA 13 0.0030
279 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 50 0.0029
280 GINGIVAL SWELLING 13 0.0029
281 PNEUMONIA BACTERIAL 27 0.0029
282 PERIPHERAL ISCHAEMIA 12 0.0029
283 HEPATIC ENZYME INCREASED 200 0.0029
284 THROMBOSIS 236 0.0029
285 CLOSTRIDIUM DIFFICILE COLITIS 31 0.0029
286 CACHEXIA 15 0.0029
287 DRUG DIVERSION 18 0.0029
288 CATHETER SITE INFECTION 11 0.0029
289 SPINAL STENOSIS 12 0.0029
290 UPPER GASTROINTESTINAL HAEMORRHAGE 48 0.0029
291 MUSCLE RIGIDITY 34 0.0028
292 INTERNATIONAL NORMALISED RATIO INCREASED 81 0.0028
293 INCONTINENCE 30 0.0028
294 HYPERVOLAEMIA 14 0.0028
295 LUNG INFILTRATION 25 0.0028
296 HYPOALBUMINAEMIA 22 0.0028
297 FAECES HARD 11 0.0028
298 LEFT VENTRICULAR HYPERTROPHY 12 0.0028
299 TEARFULNESS 12 0.0028
300 PNEUMONIA FUNGAL 11 0.0028
301 IMPAIRED GASTRIC EMPTYING 38 0.0028
302 INTENTIONAL PRODUCT MISUSE 244 0.0028
303 HEPATIC LESION 12 0.0028
304 HYPOTHYROIDISM 88 0.0028
305 FEBRILE NEUTROPENIA 181 0.0027
306 ORAL DISORDER 20 0.0027
307 HAEMATOCRIT DECREASED 54 0.0027
308 PERIPHERAL VASCULAR DISORDER 14 0.0027
309 TRISMUS 14 0.0027
310 BRADYKINESIA 16 0.0027
311 OSTEOPENIA 41 0.0027
312 APLASTIC ANAEMIA 14 0.0027
313 RENAL FAILURE 354 0.0027
314 TRICUSPID VALVE INCOMPETENCE 21 0.0026
315 ATRIAL FLUTTER 21 0.0026
316 HYPOKINESIA 38 0.0026
317 COMPRESSION FRACTURE 14 0.0026
318 DIABETES MELLITUS 199 0.0026
319 QUALITY OF LIFE DECREASED 35 0.0026
320 INTERVERTEBRAL DISC DEGENERATION 24 0.0026
321 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 16 0.0026
322 HYPOPHAGIA 66 0.0026
323 SCOLIOSIS 16 0.0026
324 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 14 0.0026
325 LUNG NEOPLASM MALIGNANT 105 0.0026
326 BLOOD PROLACTIN INCREASED 12 0.0025
327 FALL 846 0.0025
328 SPINAL COMPRESSION FRACTURE 21 0.0025
329 HYDRONEPHROSIS 19 0.0025
330 GENERAL SYMPTOM 19 0.0025
331 ENDOCARDITIS 13 0.0025
332 URINARY INCONTINENCE 75 0.0025
333 TOXICITY TO VARIOUS AGENTS 426 0.0025
334 PNEUMONIA 816 0.0025
335 GINGIVAL PAIN 20 0.0025
336 PROTHROMBIN TIME PROLONGED 15 0.0025
337 TUMOUR LYSIS SYNDROME 22 0.0025
338 METASTASES TO BONE 41 0.0025
339 ILEUS 31 0.0025
340 WEIGHT FLUCTUATION 26 0.0025
341 ENTEROCOCCAL INFECTION 12 0.0025
342 BLOOD LACTIC ACID INCREASED 13 0.0025
343 DRY MOUTH 200 0.0025
344 NEPHROPATHY 23 0.0025
345 LARGE INTESTINE PERFORATION 17 0.0024
346 POLYP 16 0.0024
347 HYPOMAGNESAEMIA 34 0.0024
348 RESPIRATORY FAILURE 177 0.0024
349 TACHYPNOEA 33 0.0024
350 RENAL INJURY 72 0.0024
351 BLOOD ALKALINE PHOSPHATASE INCREASED 60 0.0024
352 ANHEDONIA 63 0.0024
353 CYTOKINE RELEASE SYNDROME 48 0.0024
354 DIVERTICULUM 17 0.0024
355 GROIN PAIN 21 0.0024
356 SKIN LACERATION 26 0.0024
357 MITRAL VALVE INCOMPETENCE 27 0.0024
358 PATHOLOGICAL FRACTURE 12 0.0024
359 TRANSIENT ISCHAEMIC ATTACK 79 0.0023
360 HAEMATEMESIS 59 0.0023
361 LUNG DISORDER 114 0.0023
362 MOUTH HAEMORRHAGE 17 0.0023
363 MYOPATHY 20 0.0023
364 ASPARTATE AMINOTRANSFERASE INCREASED 123 0.0023
365 HICCUPS 19 0.0023
366 BLOOD PRESSURE DIASTOLIC DECREASED 17 0.0023
367 URINARY TRACT INFECTION 390 0.0023
368 SPEECH DISORDER 119 0.0023
369 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 109 0.0023
370 PRODUCTIVE COUGH 108 0.0023
371 CHOLANGITIS 14 0.0023
372 HAEMORRHOIDS 44 0.0023
373 CARDIOVASCULAR DISORDER 57 0.0022
374 SUBDURAL HAEMATOMA 32 0.0022
375 DRUG ABUSE 186 0.0022
376 PYREXIA 770 0.0022
377 DIABETIC NEUROPATHY 11 0.0022
378 BOWEL MOVEMENT IRREGULARITY 17 0.0022
379 RENAL FAILURE ACUTE 94 0.0022
380 BLOOD UREA INCREASED 37 0.0022
381 BLOOD LACTATE DEHYDROGENASE INCREASED 35 0.0022
382 HYDROCEPHALUS 12 0.0022
383 SWELLING 206 0.0022
384 ECCHYMOSIS 15 0.0022
385 RIB FRACTURE 45 0.0022
386 SEPTIC SHOCK 95 0.0022
387 INTESTINAL ISCHAEMIA 12 0.0022
388 KLEBSIELLA INFECTION 11 0.0022
389 TORSADE DE POINTES 17 0.0022
390 LYMPHOCYTE COUNT DECREASED 38 0.0021
391 PNEUMOTHORAX 34 0.0021
392 CELLULITIS 108 0.0021
393 DEVICE OCCLUSION 30 0.0021
394 VOMITING 1002 0.0021
395 GASTRITIS 56 0.0021
396 INTESTINAL OBSTRUCTION 80 0.0021
397 COVID-19 PNEUMONIA 25 0.0021
398 GLOMERULAR FILTRATION RATE DECREASED 26 0.0021
399 CARDIOMEGALY 26 0.0021
400 SENSORY LOSS 17 0.0021
401 BACTERAEMIA 25 0.0021
402 DRUG INTERACTION 334 0.0021
403 NEUTROPENIC SEPSIS 15 0.0021
404 HERPES VIRUS INFECTION 12 0.0021
405 DIPLOPIA 54 0.0021
406 ELECTROLYTE IMBALANCE 24 0.0021
407 CONDITION AGGRAVATED 627 0.0021
408 OXYGEN SATURATION DECREASED 115 0.0020
409 HAEMATURIA 70 0.0020
410 HEMIPLEGIA 17 0.0020
411 MUSCULOSKELETAL STIFFNESS 179 0.0020
412 BRUXISM 11 0.0020
413 FLANK PAIN 19 0.0020
414 RIGHT VENTRICULAR FAILURE 14 0.0020
415 HEAD INJURY 63 0.0020
416 TACHYCARDIA 176 0.0020
417 STEVENS-JOHNSON SYNDROME 44 0.0020
418 AFFECT LABILITY 19 0.0020
419 BLOOD SODIUM DECREASED 37 0.0020
420 INTESTINAL PERFORATION 22 0.0020
421 TERMINAL STATE 13 0.0019
422 CONCUSSION 15 0.0019
423 SOMNOLENCE 390 0.0019
424 SENSORY DISTURBANCE 31 0.0019
425 HIP FRACTURE 62 0.0019
426 PRE-EXISTING CONDITION IMPROVED 12 0.0019
427 DYSKINESIA 78 0.0019
428 DEHYDRATION 254 0.0019
429 ASTHMA 215 0.0019
430 BEDRIDDEN 25 0.0019
431 SPINAL DISORDER 18 0.0019
432 DRUG INTOLERANCE 183 0.0019
433 JOINT EFFUSION 13 0.0019
434 HYPERKALAEMIA 66 0.0019
435 HAEMORRHAGE INTRACRANIAL 28 0.0019
436 AUTOIMMUNE HEPATITIS 13 0.0019
437 BRADYCARDIA 99 0.0019
438 BONE DISORDER 34 0.0019
439 SUBARACHNOID HAEMORRHAGE 19 0.0019
440 HYPERCALCAEMIA 23 0.0019
441 PULMONARY OEDEMA 83 0.0019
442 RESPIRATORY DISTRESS 51 0.0018
443 HEPATITIS ACUTE 12 0.0018
444 MYOCLONUS 22 0.0018
445 TOXIC EPIDERMAL NECROLYSIS 28 0.0018
446 LETHARGY 106 0.0018
447 URINE OUTPUT DECREASED 16 0.0018
448 LIPASE INCREASED 14 0.0018
449 GANGRENE 11 0.0018
450 ESCHERICHIA INFECTION 15 0.0018
451 MUSCULOSKELETAL CHEST PAIN 28 0.0018
452 PAIN 1111 0.0018
453 INGUINAL HERNIA 11 0.0018
454 RESPIRATORY RATE INCREASED 16 0.0018
455 BRAIN INJURY 18 0.0018
456 APHONIA 25 0.0018
457 WEIGHT DECREASED 500 0.0018
458 CYSTITIS 57 0.0018
459 INFUSION SITE ERYTHEMA 15 0.0018
460 MAJOR DEPRESSION 13 0.0018
461 POSTOPERATIVE WOUND INFECTION 12 0.0018
462 HAEMOGLOBIN DECREASED 182 0.0018
463 POOR QUALITY SLEEP 38 0.0018
464 ACUTE MYOCARDIAL INFARCTION 52 0.0018
465 RENAL CYST 14 0.0018
466 LOWER GASTROINTESTINAL HAEMORRHAGE 13 0.0018
467 ALTERED STATE OF CONSCIOUSNESS 38 0.0018
468 MIOSIS 14 0.0017
469 DYSPHONIA 102 0.0017
470 PLASMA CELL MYELOMA 68 0.0017
471 NAUSEA 1374 0.0017
472 LARGE INTESTINE POLYP 12 0.0017
473 BLOOD POTASSIUM DECREASED 52 0.0017
474 SWOLLEN TONGUE 54 0.0017
475 PETECHIAE 18 0.0017
476 DEEP VEIN THROMBOSIS 112 0.0017
477 GASTROINTESTINAL HAEMORRHAGE 144 0.0017
478 CARDIAC ARREST 142 0.0017
479 MASS 24 0.0017
480 ABNORMAL FAECES 14 0.0017
481 LACERATION 16 0.0017
482 TREMOR 282 0.0017
483 OSTEOARTHRITIS 72 0.0017
484 EMBOLISM 14 0.0017
485 GASTRIC ULCER 32 0.0017
486 FACIAL PAIN 15 0.0017
487 EOSINOPHIL COUNT INCREASED 14 0.0017
488 SUPRAVENTRICULAR TACHYCARDIA 16 0.0017
489 CONFUSIONAL STATE 270 0.0017
490 SEROTONIN SYNDROME 32 0.0017
491 HEMIPARESIS 28 0.0017
492 CARDIAC FAILURE ACUTE 11 0.0016
493 RED BLOOD CELL COUNT DECREASED 47 0.0016
494 WOUND INFECTION 18 0.0016
495 DYSPHAGIA 156 0.0016
496 MUCOSAL INFLAMMATION 43 0.0016
497 ATRIAL FIBRILLATION 159 0.0016
498 PSEUDOMONAS INFECTION 14 0.0016
499 INCREASED TENDENCY TO BRUISE 15 0.0016
500 OSTEOPOROSIS 67 0.0016
501 GAMMA-GLUTAMYLTRANSFERASE INCREASED 36 0.0016
502 DEVICE RELATED INFECTION 25 0.0016
503 LIVER FUNCTION TEST ABNORMAL 47 0.0016
504 HALLUCINATION, VISUAL 34 0.0016
505 ASTHENIA 605 0.0016
506 OSTEOMYELITIS 29 0.0016
507 PULMONARY HYPERTENSION 33 0.0016
508 LIMB INJURY 43 0.0016
509 RHABDOMYOLYSIS 66 0.0016
510 APATHY 23 0.0016
511 MYOCARDITIS 18 0.0016
512 HALLUCINATION 118 0.0016
513 DUODENAL ULCER 11 0.0016
514 CARDIO-RESPIRATORY ARREST 65 0.0016
515 EATING DISORDER 33 0.0015
516 OEDEMA 84 0.0015
517 SKIN ULCER 40 0.0015
518 HIATUS HERNIA 20 0.0015
519 APNOEA 12 0.0015
520 PRODUCT USE IN UNAPPROVED INDICATION 382 0.0015
521 SEIZURE 178 0.0015
522 DISORIENTATION 61 0.0015
523 EXOSTOSIS 14 0.0015
524 HYPOCALCAEMIA 29 0.0015
525 GASTROINTESTINAL INFLAMMATION 12 0.0015
526 SKIN LESION 42 0.0015
527 INADEQUATE ANALGESIA 13 0.0015
528 TRANSFUSION 16 0.0015
529 ORAL PAIN 34 0.0015
530 PANCREATITIS ACUTE 34 0.0015
531 PERSONALITY CHANGE 14 0.0015
532 CARDIAC FAILURE CONGESTIVE 121 0.0015
533 ELECTROCARDIOGRAM QT PROLONGED 54 0.0015
534 MELAENA 33 0.0015
535 DYSPNOEA 847 0.0015
536 OBSESSIVE-COMPULSIVE DISORDER 12 0.0015
537 LIVER DISORDER 66 0.0015
538 WHITE BLOOD CELL COUNT INCREASED 57 0.0015
539 FEMUR FRACTURE 46 0.0015
540 METASTASES TO LIVER 26 0.0015
541 SINUS TACHYCARDIA 21 0.0015
542 METASTASES TO CENTRAL NERVOUS SYSTEM 19 0.0015
543 TOOTH ABSCESS 15 0.0015
544 PNEUMONITIS 40 0.0015
545 PARALYSIS 21 0.0015
546 RESPIRATORY TRACT INFECTION 38 0.0015
547 HYPERTENSION 308 0.0015
548 TARDIVE DYSKINESIA 41 0.0015
549 TOOTH FRACTURE 16 0.0014
550 SINUS BRADYCARDIA 14 0.0014
551 IRRITABLE BOWEL SYNDROME 31 0.0014
552 HAEMODYNAMIC INSTABILITY 11 0.0014
553 FLUID OVERLOAD 21 0.0014
554 PULMONARY CONGESTION 19 0.0014
555 COAGULOPATHY 24 0.0014
556 VITAMIN D DEFICIENCY 14 0.0014
557 COORDINATION ABNORMAL 20 0.0014
558 PANCYTOPENIA 80 0.0014
559 FAECES DISCOLOURED 31 0.0014
560 CHOLECYSTITIS 17 0.0014
561 FOOT FRACTURE 27 0.0014
562 MOUTH ULCERATION 30 0.0014
563 JOINT DISLOCATION 15 0.0014
564 SUDDEN DEATH 15 0.0014
565 LYMPHADENOPATHY 50 0.0014
566 FLATULENCE 80 0.0014
567 DIALYSIS 20 0.0014
568 HAEMORRHAGIC STROKE 11 0.0014
569 THROMBOCYTOPENIA 157 0.0014
570 SALIVARY HYPERSECRETION 14 0.0014
571 GASTROENTERITIS VIRAL 25 0.0014
572 ABSCESS 22 0.0014
573 ERYTHEMA 283 0.0014
574 CLOSTRIDIUM DIFFICILE INFECTION 30 0.0014
575 FRACTURE 26 0.0014
576 MENTAL IMPAIRMENT 33 0.0014
577 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 12 0.0014
578 TEMPERATURE INTOLERANCE 14 0.0014
579 MUSCULAR WEAKNESS 154 0.0014
580 LUNG INFECTION 21 0.0014
581 CIRCULATORY COLLAPSE 23 0.0013
582 POLYURIA 11 0.0013
583 EAR PAIN 26 0.0013
584 FEEDING DISORDER 27 0.0013
585 PHARYNGEAL SWELLING 13 0.0013
586 HEART RATE IRREGULAR 30 0.0013
587 DYSPNOEA EXERTIONAL 50 0.0013
588 HEPATIC FAILURE 40 0.0013
589 INTERVERTEBRAL DISC PROTRUSION 29 0.0013
590 TOOTHACHE 24 0.0013
591 LIP DRY 12 0.0013
592 HYPOGLYCAEMIA 64 0.0013
593 HYPERGLYCAEMIA 48 0.0013
594 PATHOGEN RESISTANCE 12 0.0013
595 DECREASED APPETITE 305 0.0013
596 SLEEP APNOEA SYNDROME 25 0.0013
597 OFF LABEL USE 1146 0.0013
598 STAPHYLOCOCCAL INFECTION 43 0.0013
599 DYSSTASIA 38 0.0013
600 NEUTROPHIL COUNT DECREASED 53 0.0013
601 METASTASES TO LUNG 15 0.0013
602 C-REACTIVE PROTEIN INCREASED 47 0.0013
603 APHASIA 39 0.0013
604 FACIAL PARALYSIS 11 0.0013
605 ACUTE MYELOID LEUKAEMIA 20 0.0013
606 BLOOD PRESSURE SYSTOLIC INCREASED 25 0.0013
607 ANURIA 11 0.0013
608 DYSURIA 47 0.0013
609 GASTROINTESTINAL PAIN 14 0.0013
610 JOINT RANGE OF MOTION DECREASED 17 0.0013
611 ABDOMINAL PAIN UPPER 260 0.0013
612 HYPERTENSIVE CRISIS 14 0.0013
613 EOSINOPHILIA 22 0.0013
614 PERITONITIS 26 0.0013
615 PERICARDIAL EFFUSION 29 0.0013
616 CARDIAC FAILURE 100 0.0012
617 NEUROPATHY PERIPHERAL 118 0.0012
618 STATUS EPILEPTICUS 14 0.0012
619 SYNCOPE 124 0.0012
620 PERIPHERAL COLDNESS 17 0.0012
621 ALANINE AMINOTRANSFERASE INCREASED 76 0.0012
622 GASTROENTERITIS 18 0.0012
623 LIP SWELLING 41 0.0012
624 CHOKING 24 0.0012
625 EJECTION FRACTION DECREASED 19 0.0012
626 STOMATITIS 74 0.0012
627 PARANOIA 21 0.0012
628 CARDIOMYOPATHY 18 0.0012
629 TYPE 2 DIABETES MELLITUS 41 0.0012
630 SKIN HAEMORRHAGE 18 0.0012
631 TOOTH INFECTION 16 0.0012
632 OSTEONECROSIS OF JAW 30 0.0012
633 ABNORMAL BEHAVIOUR 48 0.0012
634 MALAISE 524 0.0012
635 COLD SWEAT 21 0.0012
636 GAIT DISTURBANCE 228 0.0012
637 EMPHYSEMA 12 0.0012
638 BRAIN OEDEMA 15 0.0012
639 BONE DENSITY DECREASED 37 0.0012
640 NIGHT SWEATS 38 0.0012
641 ISCHAEMIC STROKE 21 0.0012
642 DENTAL CARIES 13 0.0012
643 RESTLESSNESS 43 0.0012
644 BACK PAIN 272 0.0012
645 SCAR 20 0.0012
646 GASTROINTESTINAL DISORDER 104 0.0012
647 SKIN INFECTION 13 0.0012
648 DELUSION 18 0.0012
649 BLISTER 65 0.0012
650 VENTRICULAR EXTRASYSTOLES 12 0.0012
651 NEPHROLITHIASIS 53 0.0012
652 BURSITIS 14 0.0012
653 DRUG LEVEL INCREASED 19 0.0011
654 POST PROCEDURAL COMPLICATION 22 0.0011
655 LOWER LIMB FRACTURE 22 0.0011
656 PLATELET COUNT DECREASED 122 0.0011
657 CYTOPENIA 14 0.0011
658 LACTIC ACIDOSIS 37 0.0011
659 MYOCARDIAL ISCHAEMIA 13 0.0011
660 CHEST PAIN 211 0.0011
661 CHILLS 133 0.0011
662 DIZZINESS POSTURAL 11 0.0011
663 NEUTROPENIA 154 0.0011
664 GENERALISED OEDEMA 14 0.0011
665 BONE LOSS 17 0.0011
666 DIABETES MELLITUS INADEQUATE CONTROL 20 0.0011
667 GALLBLADDER DISORDER 20 0.0011
668 CEREBRAL HAEMORRHAGE 40 0.0011
669 BLOOD POTASSIUM INCREASED 18 0.0011
670 BLOOD URINE PRESENT 21 0.0011
671 MULTI-ORGAN FAILURE 19 0.0011
672 OESOPHAGITIS 12 0.0011
673 PERITONITIS BACTERIAL 11 0.0011
674 MALIGNANT NEOPLASM PROGRESSION 111 0.0011
675 CYANOSIS 17 0.0011
676 CONTUSION 104 0.0011
677 MOTOR DYSFUNCTION 11 0.0011
678 BLOOD CREATINE PHOSPHOKINASE INCREASED 31 0.0011
679 AMNESIA 70 0.0011
680 AGITATION 79 0.0011
681 PLATELET COUNT INCREASED 14 0.0011
682 ADRENAL INSUFFICIENCY 13 0.0011
683 EPISTAXIS 80 0.0011
684 VERTIGO 65 0.0011
685 COVID-19 187 0.0011
686 METABOLIC ACIDOSIS 34 0.0011
687 HYPERBILIRUBINAEMIA 11 0.0011
688 TOOTH LOSS 22 0.0011
689 POLLAKIURIA 44 0.0011
690 ANGINA PECTORIS 30 0.0010
691 HEADACHE 656 0.0010
692 RESTLESS LEGS SYNDROME 19 0.0010
693 TOOTH EXTRACTION 13 0.0010
694 SHOCK 24 0.0010
695 AGEUSIA 26 0.0010
696 HYPERHIDROSIS 134 0.0010
697 ANKLE FRACTURE 16 0.0010
698 MANIA 17 0.0010
699 ANXIETY 293 0.0010
700 VENTRICULAR TACHYCARDIA 17 0.0010
701 BODY TEMPERATURE INCREASED 21 0.0010
702 SPLENOMEGALY 12 0.0010
703 BREAST CANCER METASTATIC 11 0.0010
704 SPINAL PAIN 12 0.0010
705 RENAL IMPAIRMENT 86 0.0010
706 SEXUAL DYSFUNCTION 12 0.0010
707 BLOOD PRESSURE DECREASED 68 0.0010
708 HEPATIC STEATOSIS 19 0.0010
709 COUGH 286 0.0010
710 DRUG INEFFECTIVE 1343 0.0010
711 LIVER INJURY 25 0.0010
712 DEPRESSION 230 0.0010
713 EXTRAPYRAMIDAL DISORDER 25 0.0010
714 IMMUNODEFICIENCY 15 0.0010
715 HAEMATOMA 26 0.0010
716 FLUID RETENTION 51 0.0010
717 PAIN IN JAW 28 0.0010
718 GAIT INABILITY 33 0.0010
719 WHITE BLOOD CELL COUNT DECREASED 107 0.0010
720 NECK PAIN 55 0.0010
721 NO THERAPEUTIC RESPONSE 12 0.0010
722 DRUG DEPENDENCE 158 0.0010
723 RESPIRATORY ARREST 27 0.0010
724 CHROMATURIA 22 0.0010
725 PAIN IN EXTREMITY 287 0.0010
726 ORAL HERPES 19 0.0010
727 MUSCLE TWITCHING 22 0.0010
728 DRUG TOXICITY 13 0.0010
729 ARRHYTHMIA 45 0.0009
730 CANDIDA INFECTION 16 0.0009
731 CENTRAL NERVOUS SYSTEM LESION 13 0.0009
732 BRONCHITIS 70 0.0009
733 LOSS OF CONSCIOUSNESS 121 0.0009
734 FATIGUE 732 0.0009
735 HEART RATE DECREASED 33 0.0009
736 HEPATIC FUNCTION ABNORMAL 35 0.0009
737 RASH PAPULAR 21 0.0009
738 MOVEMENT DISORDER 30 0.0009
739 HUNGER 13 0.0009
740 INFUSION SITE PAIN 12 0.0009
741 DYSTONIA 18 0.0009
742 DISTURBANCE IN ATTENTION 50 0.0009
743 CONVULSION 53 0.0009
744 DISSEMINATED INTRAVASCULAR COAGULATION 13 0.0009
745 EYE PAIN 52 0.0009
746 SEASONAL ALLERGY 13 0.0009
747 HOSPITALISATION 141 0.0009
748 MEDICATION ERROR 51 0.0009
749 INSURANCE ISSUE 14 0.0009
750 SKIN DISCOLOURATION 42 0.0009
751 BRONCHOSPASM 13 0.0009
752 ACTIVITIES OF DAILY LIVING IMPAIRED 18 0.0009
753 FIBROMYALGIA 22 0.0009
754 ACUTE RESPIRATORY DISTRESS SYNDROME 16 0.0009
755 TENDONITIS 14 0.0009
756 HEAD DISCOMFORT 16 0.0009
757 CEREBRAL INFARCTION 22 0.0009
758 LEUKOPENIA 45 0.0009
759 SKIN DISORDER 30 0.0009
760 TOOTH DISORDER 20 0.0009
761 MYELODYSPLASTIC SYNDROME 13 0.0009
762 DIARRHOEA 580 0.0009
763 DEATH 774 0.0009
764 THIRST 16 0.0009
765 FACE OEDEMA 15 0.0009
766 MOOD SWINGS 28 0.0009
767 ACUTE HEPATIC FAILURE 12 0.0009
768 MUSCULOSKELETAL PAIN 46 0.0009
769 BLOOD PRESSURE FLUCTUATION 21 0.0009
770 MENTAL DISORDER 38 0.0009
771 DISCOMFORT 53 0.0009
772 OROPHARYNGEAL PAIN 80 0.0009
773 CONJUNCTIVITIS 16 0.0009
774 IMPAIRED HEALING 28 0.0009
775 MUSCLE SPASMS 156 0.0008
776 INFECTION 123 0.0008
777 INSOMNIA 226 0.0008
778 HEART RATE INCREASED 84 0.0008
779 INJURY 59 0.0008
780 PERIPHERAL SWELLING 129 0.0008
781 MEMORY IMPAIRMENT 115 0.0008
782 DISEASE PROGRESSION 99 0.0008
783 DIABETIC KETOACIDOSIS 20 0.0008
784 GLAUCOMA 16 0.0008
785 ANGER 28 0.0008
786 SUICIDE ATTEMPT 50 0.0008
787 PRODUCT DOSE OMISSION ISSUE 242 0.0008
788 HALLUCINATION, AUDITORY 13 0.0008
789 RASH ERYTHEMATOUS 39 0.0008
790 PRODUCT USE ISSUE 153 0.0008
791 SWELLING FACE 53 0.0008
792 INFLAMMATION 42 0.0008
793 PALPITATIONS 95 0.0008
794 ILLNESS 83 0.0008
795 ABDOMINAL DISCOMFORT 135 0.0008
796 TREATMENT NONCOMPLIANCE 44 0.0008
797 CEREBROVASCULAR ACCIDENT 136 0.0008
798 NERVOUS SYSTEM DISORDER 25 0.0008
799 SPINAL FRACTURE 16 0.0008
800 ABNORMAL DREAMS 22 0.0008
801 DIZZINESS 397 0.0008
802 RENAL DISORDER 37 0.0008
803 DIVERTICULITIS 22 0.0008
804 CONTRAINDICATED PRODUCT ADMINISTERED 24 0.0008
805 BLOOD TRIGLYCERIDES INCREASED 14 0.0008
806 MULTIPLE FRACTURES 13 0.0008
807 HYPOACUSIS 34 0.0008
808 SKIN CANCER 17 0.0008
809 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 142 0.0008
810 GENERALISED TONIC-CLONIC SEIZURE 13 0.0008
811 CHOLESTASIS 15 0.0008
812 AGGRESSION 39 0.0008
813 EMOTIONAL DISTRESS 94 0.0008
814 HYPOAESTHESIA 115 0.0008
815 DERMATITIS 16 0.0008
816 KNEE ARTHROPLASTY 16 0.0008
817 HYPERTHYROIDISM 11 0.0008
818 COMPLICATION ASSOCIATED WITH DEVICE 11 0.0008
819 PANCREATITIS 40 0.0008
820 GLYCOSYLATED HAEMOGLOBIN INCREASED 19 0.0008
821 SCIATICA 12 0.0008
822 BONE PAIN 44 0.0008
823 SKIN EXFOLIATION 63 0.0007
824 HEPATIC CIRRHOSIS 14 0.0007
825 FULL BLOOD COUNT DECREASED 15 0.0007
826 TASTE DISORDER 15 0.0007
827 BLOOD PRESSURE INCREASED 113 0.0007
828 COLON CANCER 11 0.0007
829 RASH GENERALISED 19 0.0007
830 MIGRAINE 70 0.0007
831 ABASIA 18 0.0007
832 GASTRIC DISORDER 25 0.0007
833 ANGIOEDEMA 32 0.0007
834 NIGHTMARE 25 0.0007
835 PHARYNGEAL OEDEMA 11 0.0007
836 GLOSSODYNIA 16 0.0007
837 OVERDOSE 154 0.0007
838 PARAESTHESIA 112 0.0007
839 LIMB DISCOMFORT 22 0.0007
840 BLOOD GLUCOSE DECREASED 34 0.0007
841 SINUS DISORDER 14 0.0007
842 BASAL CELL CARCINOMA 11 0.0007
843 BRAIN FOG 11 0.0007
844 PRESCRIBED UNDERDOSE 14 0.0007
845 INFLUENZA 78 0.0007
846 PALLOR 19 0.0007
847 MUSCULOSKELETAL DISCOMFORT 12 0.0007
848 TINNITUS 32 0.0007
849 VIRAL INFECTION 23 0.0007
850 DEAFNESS 18 0.0007
851 EYE PRURITUS 23 0.0007
852 PROTEINURIA 13 0.0007
853 DRY EYE 34 0.0007
854 DEPRESSED MOOD 36 0.0007
855 VISION BLURRED 93 0.0007
856 EAR INFECTION 18 0.0007
857 RASH MACULO-PAPULAR 15 0.0007
858 CHEST DISCOMFORT 69 0.0007
859 INTENTIONAL PRODUCT USE ISSUE 59 0.0007
860 RESPIRATORY DISORDER 20 0.0007
861 THERAPY NON-RESPONDER 30 0.0007
862 INTENTIONAL DOSE OMISSION 19 0.0007
863 THROAT TIGHTNESS 18 0.0007
864 MYALGIA 113 0.0007
865 CARDIAC DISORDER 62 0.0007
866 ERECTILE DYSFUNCTION 17 0.0007
867 LACRIMATION INCREASED 20 0.0007
868 CYTOMEGALOVIRUS INFECTION 11 0.0007
869 DRUG RESISTANCE 17 0.0007
870 LOCALISED INFECTION 16 0.0007
871 NEOPLASM PROGRESSION 23 0.0007
872 WEIGHT INCREASED 148 0.0007
873 UNEVALUABLE EVENT 50 0.0007
874 MYOCARDIAL INFARCTION 115 0.0007
875 THERAPY INTERRUPTED 47 0.0007
876 CATARACT 39 0.0007
877 EPILEPSY 20 0.0007
878 ARTHRITIS 51 0.0006
879 GYNAECOMASTIA 20 0.0006
880 RASH PRURITIC 35 0.0006
881 THINKING ABNORMAL 12 0.0006
882 PRODUCT PRESCRIBING ISSUE 14 0.0006
883 MULTIPLE SCLEROSIS RELAPSE 44 0.0006
884 DRUG-INDUCED LIVER INJURY 20 0.0006
885 FEELING HOT 39 0.0006
886 SUICIDAL IDEATION 58 0.0006
887 MUSCULOSKELETAL DISORDER 12 0.0006
888 FUNGAL INFECTION 21 0.0006
889 RASH MACULAR 22 0.0006
890 INCREASED APPETITE 12 0.0006
891 BURNING SENSATION 44 0.0006
892 MULTIPLE SCLEROSIS 30 0.0006
893 THERAPY CESSATION 32 0.0006
894 ERUCTATION 12 0.0006
895 SKIN FISSURES 12 0.0006
896 KIDNEY INFECTION 12 0.0006
897 HERPES ZOSTER 35 0.0006
898 RHINORRHOEA 39 0.0006
899 NASAL CONGESTION 35 0.0006
900 SINUSITIS 61 0.0006
901 PRODUCT ADMINISTRATION ERROR 12 0.0006
902 AGRANULOCYTOSIS 11 0.0006
903 ARTHRALGIA 245 0.0006
904 PRURITUS 225 0.0006
905 ANAPHYLACTIC SHOCK 15 0.0006
906 LABORATORY TEST ABNORMAL 17 0.0006
907 ACCIDENTAL OVERDOSE 21 0.0006
908 COMA 27 0.0006
909 HYPERSOMNIA 16 0.0006
910 RASH 243 0.0006
911 DISABILITY 11 0.0006
912 ABDOMINAL PAIN LOWER 14 0.0006
913 BLOOD PRESSURE ABNORMAL 11 0.0006
914 DEVICE DISLOCATION 24 0.0006
915 OSTEONECROSIS 18 0.0005
916 HEPATITIS 14 0.0005
917 HAEMORRHAGE 57 0.0005
918 ADVERSE DRUG REACTION 47 0.0005
919 CRYING 19 0.0005
920 PANIC ATTACK 19 0.0005
921 FEAR 14 0.0005
922 EMOTIONAL DISORDER 16 0.0005
923 THROAT IRRITATION 23 0.0005
924 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 13 0.0005
925 WOUND 14 0.0005
926 SURGERY 29 0.0005
927 VISUAL IMPAIRMENT 61 0.0005
928 HOT FLUSH 37 0.0005
929 ANAPHYLACTIC REACTION 27 0.0005
930 NEOPLASM MALIGNANT 32 0.0005
931 THERAPEUTIC PRODUCT EFFECT DECREASED 21 0.0005
932 INTENTIONAL OVERDOSE 30 0.0005
933 BLOOD GLUCOSE INCREASED 88 0.0005
934 IRRITABILITY 28 0.0005
935 EYE SWELLING 17 0.0005
936 JOINT SWELLING 55 0.0005
937 VISUAL ACUITY REDUCED 15 0.0005
938 JAUNDICE 12 0.0004
939 PAIN OF SKIN 12 0.0004
940 HYPERSENSITIVITY 82 0.0004
941 URTICARIA 74 0.0004
942 GASTRIC CANCER 11 0.0004
943 DYSGEUSIA 32 0.0004
944 ILL-DEFINED DISORDER 26 0.0004
945 DRY SKIN 57 0.0004
946 PANCREATIC CARCINOMA 12 0.0004
947 ARTHROPATHY 23 0.0004
948 ROAD TRAFFIC ACCIDENT 17 0.0004
949 THERAPEUTIC RESPONSE UNEXPECTED 18 0.0004
950 FEELING ABNORMAL 94 0.0004
951 FLUSHING 39 0.0004
952 NEEDLE ISSUE 11 0.0004
953 INFLUENZA LIKE ILLNESS 31 0.0004
954 NASOPHARYNGITIS 69 0.0004
955 PREMATURE BABY 11 0.0004
956 DRUG WITHDRAWAL SYNDROME 32 0.0004
957 DEVICE ISSUE 32 0.0004
958 UNDERDOSE 26 0.0004
959 INTERSTITIAL LUNG DISEASE 17 0.0004
960 INCORRECT DOSE ADMINISTERED 79 0.0003
961 ECZEMA 18 0.0003
962 TREATMENT FAILURE 27 0.0003
963 EXTRA DOSE ADMINISTERED 13 0.0003
964 OCULAR HYPERAEMIA 15 0.0003
965 PRODUCT DOSE OMISSION 20 0.0003
966 ALOPECIA 59 0.0003
967 EYE IRRITATION 17 0.0003
968 ADVERSE EVENT 27 0.0003
969 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 16 0.0003
970 THERAPEUTIC RESPONSE DECREASED 17 0.0003
971 NERVOUSNESS 14 0.0003
972 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 18 0.0003
973 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 50 0.0002
974 NO ADVERSE EVENT 44 0.0002
975 RHEUMATOID ARTHRITIS 27 0.0002
976 INJECTION SITE REACTION 16 0.0002
977 ACNE 17 0.0002
978 PROSTATE CANCER 18 0.0002
979 DRUG EFFECT DECREASED 12 0.0002
980 INJECTION SITE BRUISING 17 0.0002
981 INJECTION SITE PRURITUS 14 0.0002
982 MATERNAL EXPOSURE DURING PREGNANCY 17 0.0002
983 PRODUCT QUALITY ISSUE 25 0.0002
984 BREAST CANCER 16 0.0002
985 DEVICE MALFUNCTION 12 0.0002
986 ACCIDENTAL EXPOSURE TO PRODUCT 17 0.0002
987 INJECTION SITE PAIN 47 0.0002
988 DRUG DOSE OMISSION 25 0.0002
989 INJECTION SITE HAEMORRHAGE 11 0.0001
990 PSORIASIS 17 0.0001
991 INJECTION SITE ERYTHEMA 16 0.0001